Home Cart 0 Sign in  
X

[ CAS No. 1378388-20-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 1378388-20-5
Chemical Structure| 1378388-20-5
Chemical Structure| 1378388-20-5
Structure of 1378388-20-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1378388-20-5 ]

Related Doc. of [ 1378388-20-5 ]

Alternatived Products of [ 1378388-20-5 ]

Product Details of [ 1378388-20-5 ]

CAS No. :1378388-20-5 MDL No. :MFCD29917576
Formula : C17H13ClO2 Boiling Point : -
Linear Structure Formula :- InChI Key :BBBRYVDJZUVJPB-UHFFFAOYSA-N
M.W : 284.74 Pubchem ID :69673366
Synonyms :

Calculated chemistry of [ 1378388-20-5 ]

Physicochemical Properties

Num. heavy atoms : 20
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.24
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 79.28
TPSA : 26.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.32 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.86
Log Po/w (XLOGP3) : 3.82
Log Po/w (WLOGP) : 4.27
Log Po/w (MLOGP) : 3.46
Log Po/w (SILICOS-IT) : 5.23
Consensus Log Po/w : 3.93

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.46
Solubility : 0.00996 mg/ml ; 0.000035 mol/l
Class : Moderately soluble
Log S (Ali) : -4.07
Solubility : 0.0244 mg/ml ; 0.0000856 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -6.54
Solubility : 0.0000829 mg/ml ; 0.000000291 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.77

Safety of [ 1378388-20-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1378388-20-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1378388-20-5 ]
  • Downstream synthetic route of [ 1378388-20-5 ]

[ 1378388-20-5 ] Synthesis Path-Upstream   1~8

  • 1
  • [ 1378388-20-5 ]
  • [ 1378390-29-4 ]
Reference: [1] Patent: WO2013/75029, 2013, A1,
[2] Patent: US2013/309196, 2013, A1,
[3] Patent: US2014/178336, 2014, A1,
[4] Patent: US2015/361073, 2015, A1,
  • 2
  • [ 1378388-20-5 ]
  • [ 1378391-38-8 ]
Reference: [1] Patent: US2014/178336, 2014, A1,
[2] Patent: US2015/361073, 2015, A1,
  • 3
  • [ 1378388-19-2 ]
  • [ 1378388-20-5 ]
YieldReaction ConditionsOperation in experiment
67% With palladium(II) pentavalerate; potassium carbonate; P(p-C6H4F)3; Trimethylacetic acid In N,N-dimethyl acetamide at 60℃; for 24 h; Inert atmosphere 3-chloro-10,ll-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one To a 1 L flask containing palladium(II) pivalate (1.18 g, 3.8 mmol), tri(4- fluorophenyl)phosphine (1.20 g, 3.8 mmol), pivalic acid (2.33 g, 22.8 mmol) and potassium carbonate (31.8 g, 228 mmol) was added a solution of 7-(2-bromo-5-chlorobenzyloxy)-3,4-dihydronaphthalen- l(2H)-one (27.8 g, 76.2 mmol) in dimethyacetamide (380 mL). The flask was evacuated and backfilled with argon 5 times and then stirred under argon at 60 °C for 24 hours. The reaction was cooled to room temperature and diluted with MTBE and water. The resulting biphasic mixture was stirred for 3 hours and filtered through Celite, rinsing with MTBE. The organic layer of the filtrate was separated and then washed twice with water and once with brine. The organics were then dried with magnesium sulfate, filtered, concentrated and purified by flash column chromatography(Hexanes/DCM) to yield 3-chloro-10,l l -dihydro-5H-dibenzo[c,g]chromen-8(9H)-one (14.4 g, 67percent yield) as an off-white solid.
67% With palladium(II) pentavalerate; potassium carbonate; P(p-C6H4F)3; Trimethylacetic acid In N,N-dimethyl acetamide at 60℃; for 24 h; Inert atmosphere To a 1 L flask containing palladium(II) pivalate (1.18 g, 3.8 mmol), tri(4-fluorophenyl)phosphine (1.20 g, 3.8 mmol), pivalic acid (2.33 g, 22.8 mmol) and potassium carbonate (31.8 g, 228 mmol) was added a solution of 7-(2-bromo-5-chlorobenzyloxy)-3,4-dihydronaphthalen-1(2H)-one (27.8 g, 76.2 mmol) in dimethyacetamide (380 mL). The flask was evacuated and backfilled with argon 5 times and then stirred under argon at 60° C. for 24 hours. The reaction was cooled to room temperature and diluted with MTBE and water. The resulting biphasic mixture was stirred for 3 hours and filtered through Celite, rinsing with MTBE. The organic layer of the filtrate was separated and then washed twice with water and once with brine. The organics were then dried with magnesium sulfate, filtered, concentrated and purified by flash column chromatography (Hexanes/DCM) to yield 3-chloro-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one (14.4 g, 67percent yield) as an off-white solid.
67% With palladium(II) pentavalerate; potassium carbonate; P(p-C6H4F)3; Trimethylacetic acid In N,N-dimethyl acetamide at 60℃; for 24 h; Inert atmosphere 3-Chloro-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one
To a 1 L flask containing palladium(II) pivalate (1.18 g, 3.8 mmol), tri(4-fluorophenyl)phosphine (1.20 g, 3.8 mmol), pivalic acid (2.33 g, 22.8 mmol) and potassium carbonate (31.8 g, 228 mmol) was added a solution of 7-(2-bromo-5-chlorobenzyloxy)-3,4-dihydronaphthalen-1(2H)-one (27.8 g, 76.2 mmol) in dimethyacetamide (380 mL).
The flask was evacuated and backfilled with argon 5 times and then stirred under argon at 60° C. for 24 hours.
The reaction was cooled to room temperature and diluted with MTBE and water.
The resulting biphasic mixture was stirred for 3 hours and filtered through Celite, rinsing with MTBE.
The organic layer of the filtrate was separated and then washed twice with water and once with brine.
The organics were then dried with magnesium sulfate, filtered, concentrated and purified by flash column chromatography (Hexanes/DCM) to yield 3-chloro-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one (14.4 g, 67percent yield) as an off-white solid.
14.9 g With palladium(II) pentavalerate; potassium carbonate; P(p-C6H4F)3; Trimethylacetic acid In N,N-dimethyl acetamide at 60℃; for 24 h; Inert atmosphere 27.8 g (76.2 mmol) of iv-3 was added to 380 ml of dimethylacetamide and stirred to dissolve;1.18 g (3.8 mmol) of palladium (II) pivalate, 1.20 g (3.8 mmol) of tris(4-fluorophenyl)phosphine, 2.33 g (22.8 mmol) of pivalic acid and31.8 g (228 mmol) of potassium carbonate was evacuated and refilled with argon five times;Under argon, stir at 60°C for 24 hours. The reaction was cooled to room temperature and t-butyl methyl ether and water were added.Stir for 3 hours and filter through celite and rinse with t-butyl methyl ether. The organic layer was separated, washed twice with water and once with brine. The organic layer was dried over magnesium sulfate overnight, the solid was filtered off, and the filtrate was evaporated to dryness under reduced pressure.Separation by silica gel column chromatography eluting with a mixed solvent of dichloromethane:petroleum ether (5:5) to collect the desired components,Evaporation under reduced pressure gave 14.9 g of 3-chloro-10,11-dihydro-5H-dibenzo[c,g]chromene-8(9H)-one (iv-4).
14.9 g With palladium(II) pentavalerate; potassium carbonate; P(p-C6H4F)3; Trimethylacetic acid In N,N-dimethyl acetamide at 60℃; for 24 h; Inert atmosphere The second step: add 27.8 g (76.2 mmol) iv-3380ml dimethylacetamide, stir to dissolve; add in order1.18 g (3.8 mmol) of palladium (II) pivalate,1.20g (3.8mmol)Tris(4-fluorophenyl)phosphine, 2.33 g (22.8 mmol)Pivalic acid and 31.8 g (228 mmol) of potassium carbonate were evacuated.Argon gas was backfilled 5 times; under argon, it was stirred at 60°C for 24 hours.Cool the reaction to room temperature and add t-butyl methyl ether and water.Stir for 3 hours and filter through diatomaceous earthRinse with tert-butyl methyl ether. Separate the organic layer,Wash twice with water and once with brine. The organic layer was dried over magnesium sulfate overnight, the solid was filtered off, and the filtrate was evaporated to dryness under reduced pressure. The residue was separated by silica gel column chromatography and eluted with a mixed solvent of dichloromethane:petroleum ether (5:5) to collect the desired fraction. After evaporation under reduced pressure, 14.9 g of 3-chloro-10,11-dihydro-5H-dibenzo[c,g]chromene-8(9H)-one (iv-4) was obtained.

Reference: [1] Patent: WO2013/75029, 2013, A1, . Location in patent: Page/Page column 53-55
[2] Patent: US2013/309196, 2013, A1, . Location in patent: Paragraph 0206
[3] Patent: US2014/178336, 2014, A1, . Location in patent: Paragraph 0235
[4] Patent: US2015/361073, 2015, A1, . Location in patent: Paragraph 0438
[5] Patent: CN106916134, 2017, A, . Location in patent: Paragraph 0013; 0023
[6] Patent: CN107540679, 2018, A, . Location in patent: Paragraph 0031; 0033
[7] Patent: CN107556324, 2018, A, . Location in patent: Paragraph 0030; 0031; 0033
  • 4
  • [ 22009-38-7 ]
  • [ 1378388-20-5 ]
Reference: [1] Patent: WO2013/75029, 2013, A1,
[2] Patent: US2013/309196, 2013, A1,
[3] Patent: US2014/178336, 2014, A1,
[4] Patent: US2015/361073, 2015, A1,
[5] Patent: CN107540679, 2018, A,
[6] Patent: CN107556324, 2018, A,
  • 5
  • [ 66192-24-3 ]
  • [ 1378388-20-5 ]
Reference: [1] Patent: WO2013/75029, 2013, A1,
[2] Patent: US2013/309196, 2013, A1,
[3] Patent: US2014/178336, 2014, A1,
[4] Patent: US2015/361073, 2015, A1,
[5] Patent: CN107540679, 2018, A,
[6] Patent: CN107556324, 2018, A,
  • 6
  • [ 1380084-58-1 ]
  • [ 1378388-20-5 ]
Reference: [1] Patent: CN105801553, 2016, A,
  • 7
  • [ 1072-85-1 ]
  • [ 1378388-20-5 ]
Reference: [1] Patent: CN105801553, 2016, A,
  • 8
  • [ 1993-03-9 ]
  • [ 1378388-20-5 ]
Reference: [1] Patent: CN105801553, 2016, A,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1378388-20-5 ]

Chlorides

Chemical Structure| 37674-72-9

[ 37674-72-9 ]

6-Chlorochroman-4-one

Similarity: 0.88

Chemical Structure| 220526-76-1

[ 220526-76-1 ]

(5-Chlorobenzofuran-2-yl)(4-methoxyphenyl)methanone

Similarity: 0.86

Chemical Structure| 27407-06-3

[ 27407-06-3 ]

6,7-Dichlorochroman-4-one

Similarity: 0.86

Chemical Structure| 18385-72-3

[ 18385-72-3 ]

7-Chloro-4-chromanone

Similarity: 0.84

Chemical Structure| 6552-63-2

[ 6552-63-2 ]

1-(4-Chlorophenyl)-3-(4-methoxyphenyl)prop-2-en-1-one

Similarity: 0.81

Ketones

Chemical Structure| 37674-72-9

[ 37674-72-9 ]

6-Chlorochroman-4-one

Similarity: 0.88

Chemical Structure| 220526-76-1

[ 220526-76-1 ]

(5-Chlorobenzofuran-2-yl)(4-methoxyphenyl)methanone

Similarity: 0.86

Chemical Structure| 27407-06-3

[ 27407-06-3 ]

6,7-Dichlorochroman-4-one

Similarity: 0.86

Chemical Structure| 18385-72-3

[ 18385-72-3 ]

7-Chloro-4-chromanone

Similarity: 0.84

Chemical Structure| 6552-63-2

[ 6552-63-2 ]

1-(4-Chlorophenyl)-3-(4-methoxyphenyl)prop-2-en-1-one

Similarity: 0.81

Related Parent Nucleus of
[ 1378388-20-5 ]

Other Aromatic Heterocycles

Chemical Structure| 37674-72-9

[ 37674-72-9 ]

6-Chlorochroman-4-one

Similarity: 0.88

Chemical Structure| 27407-06-3

[ 27407-06-3 ]

6,7-Dichlorochroman-4-one

Similarity: 0.86

Chemical Structure| 18385-72-3

[ 18385-72-3 ]

7-Chloro-4-chromanone

Similarity: 0.84

Chemical Structure| 49701-11-3

[ 49701-11-3 ]

8-Chlorochroman-4-one

Similarity: 0.79

Chemical Structure| 26371-48-2

[ 26371-48-2 ]

6-Chlorochroman-3-one

Similarity: 0.78